PK
Parmar Kush
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Parmar Kush, Director. Insider active across 4 companies, notably Rallybio Corp. In total, 16 disclosures have been recorded. Breakdown: 0 buy · 13 sells. Total volume traded: €11.2m. Activity tracked since 16 November 2021. The latest transaction was filed on 6 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Parmar Kush
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
10,494 shares@ US$7.000.027% mcap1.8% of flowCommon StockSEC:0001664281-26-000004:0
52,317 shares@ US$6.850.13% mcap8.6% of flowCommon StockSEC:0001664281-26-000004:1
92,444 shares@ US$7.000.24% mcap15.5% of flowCommon StockSEC:0001664281-26-000004:2
114,756 shares@ US$6.930.30% mcap25.9% of flowCommon StockSEC:0001664281-26-000002:0
1,718 shares@ US$6.850.0045% mcap0.4% of flowCommon StockSEC:0001664281-26-000002:1
200,000 shares@ US$8.8076.8% of flowCommon StockSEC:0001664281-25-000003:0
20,065 shares@ US$7.50228.0% of flowCommon StockSEC:0001415889-25-019680:0
55,735 shares@ US$6.91100.0% of flowCommon StockSEC:0001415889-25-018824:0
100,000 shares@ US$8.2013.0% of flowCommon StockSEC:0001209191-23-017538:0
3,153,333 sharesCommon StockSEC:0001104659-22-124136:0
99,671 shares@ US$12.5026.8% of flowCommon StockSEC:0001209191-22-034860:0
66,447 shares@ US$13.0018.7% of flowCommon StockSEC:0001209191-22-031969:0
139,539 shares@ US$13.0536.8% of flowCommon StockSEC:0001209191-22-008579:0
238,870 shares@ US$15.30100.0% of flowCommon StockSEC:0001209191-21-065656:0
318,616 sharesCommon StockSEC:0001104659-21-134772:0
2,784,626 sharesCommon StockSEC:0001209191-21-049823:0
About Parmar Kush
PARMAR KUSH is Administrateur and has 13 filings in total. Across the 13 sampled recent filings, all are sales, for total sell volume of EUR 10216254 between 2021-08-04 and 2026-08-03. The companies mentioned in these filings are Entrada Therapeutics, Inc., Rallybio Corp, Akouos, Inc., and Vor Biopharma Inc.